Media Center
- No
-
Category
- Show all
- Press Release
- News Article
- PR Video
- CEO Story
- Title
- Author
- Time uploaded
- Views
- Likes
- 162
- CEO Story
- CEO Story PharmAbcine to participate in BIO-Europe Spring 2022
- PharmAbcine
- 17 Mar 2022
- Views2017
- 0
- 161
- Press Release
- Press Release PharmAbcine to Present Updated Data of Its Anti-VISTA Antibody Candidate at AACR 2022
- PharmAbcine
- 9 Mar 2022
- Views2314
- 0
- 160
- Press Release
- Press Release PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial
- PharmAbcine
- 27 Feb 2022
- Views2892
- 0
- 159
- PR Video
- PR Video Biotech Showcase 2022
- PharmAbcine
- 3 Feb 2022
- Views2682
- 0
- 158
- PR Video
- PR Video Access China Biotech Forum Winter Showcase 2022
- PharmAbcine
- 28 Jan 2022
- Views2066
- 0
- 157
- Press Release
- Press Release PharmAbcine Announces First Patient Enrolled and Dosed in the Phase II Clinical Trial for the Treatment of mTNBC
- PharmAbcine
- 28 Dec 2021
- Views2710
- 0
- 156
- CEO Story
- CEO Story PharmAbcine’s story featured on Life Sciences Review BioTech APAC 2021 Edition
- PharmAbcine
- 15 Dec 2021
- Views3855
- 0
- 155
- Press Release
- Press Release PharmAbcine’s next-generation bispecific antibody drug discovery project wins a New Drug Development Fund from the government
- PharmAbcine
- 13 Dec 2021
- Views2447
- 0
- 154
- Press Release
- Press Release PharmAbcine to participate in J.P. Morgan Healthcare Conference and Biotech Showcase during “J.P. Morgan Week 2022”
- PharmAbcine
- 7 Dec 2021
- Views2431
- 0
- 153
- PR Video
- PR Video Access China Biotech Forum 2021
- PharmAbcine
- 17 Nov 2021
- Views2171
- 0